𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Limited clinical impact of anti-idursulfase antibodies developed during long-term idursulfase enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome) patients aged 5-35 years

✍ Scribed by Harmatz, Paul; Giugliani, Roberto; Mendelsohn, Nancy J.; Vellodi, Ashok; Kunes, Yune; Sciarappa, Kenneth; Bielefeld, Bonnie; Barbier, Ann J.; Pano, Arian; Hendriksz, Christian J.; Vijayaraghavan, Suresh


Book ID
122131184
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
49 KB
Volume
111
Category
Article
ISSN
1096-7192

No coin nor oath required. For personal study only.